Strategic Plan
We are pleased to present the Australia and New Zealand Sarcoma Association (ANZSA) Strategic Plan 2025-2027. This second strategic plan comes after successfully completing our Strategic Plan 2022-2024, which included 34 milestones.
The Strategic Plan 2025-2027 will continue to expand on the work we have embarked on that is driven by high-quality patient-centred clinical trials and research to improve patient survival rates and quality of life.
Download to read the full ANZSA Strategic Plan 2025-2027.
1. Improve survival rates and outcomes
2. Increase the depth and breadth of research portfolio
3. Expand and improve a comprehensive sarcoma registry for Australia and New Zealand
4. Provide every sarcoma patient with the opportunity to be involved in evidence-based sarcoma care, including research
5. To attract, develop and retain the best talent to work in sarcoma
1. To diversify funding sources to ensure ANZSA can achieve its stated purpose with a sustainable long term funding position
2. To encourage, support and celebrate philanthropic activity
3. To increase government and peer-reviewed funding to sarcoma and tumour related research projects
4. To maintain robust governance practices, implementation of the strategic plan and prudent risk management
1. To establish a framework for sarcoma professional and patient education
2. To promote sarcoma and related tumour research and clinical care to the clinical community
3. Expand and promote sarcoma guidelines and clinical care standards to the clinical community
1. To Promote sarcoma research to the wider community
2. To be a strong public advocate for patients, survivors and their families
3. To more purposefully advocate to government
4. Develop closer engagement within the sarcoma community